On World AIDS Day, the Joint United Nations Programme on HIV released new statistics: around 1.3 million people were infected last year, and approximately 40.8 million are living with the virus worldwide. Every minute, one person dies from AIDS-related causes. Amid these alarming figures, a new research approach from the University of Cologne offers hope. An international team led by German scientists identified the antibody 04_A06, which neutralized 98.5% of more than 300 HIV strains in laboratory tests. In trials with humanized mice, it permanently reduced viral load to undetectable levels. Professor Florian Klein, Director of the Institute of Virology at Cologne University Hospital, emphasized the importance of international cooperation with research centers in Africa, Nepal, and the United States. The next step is to study the antibody’s safety and effectiveness in clinical trials, paving the way for patient care. The study was supported by the Gates Foundation, the German Research Foundation (DFG), the German Center for Infection Research, and the European Research Council. At the same time, Germany continues to invest globally in combating HIV. The Global Fund partnership, which has saved more than 70 million lives since its inception, will receive an additional €1 billion in funding through a new German pledge at the G20 summit in November. These funds aim to stabilize HIV programs worldwide and strengthen health systems. Sources - Agencies